Pneumonia in Tetanus Study (BP)
Tetanus
About this trial
This is an interventional supportive care trial for Tetanus
Eligibility Criteria
Inclusion Criteria:
- Consecutive patients will be entered into the study as they are admitted to the intensive care ward with a clinical diagnosis of tetanus.
- Informed consent will be obtained from the patient or next-of-kin before randomisation.
- An envelope for the next study number will be opened in which patients will be randomly allocated to either semi-recumbent (300) or supine (00) body position. The randomisation will be created by a computer generated list.
- All health care personnel will be instructed not to change the position, unless for medical requirements.
- The correctness of the position will be checked twice daily.
- Surveillance for clinical detection of pneumonia or other infection will be done daily. If infection is suspected relevant microbiological samples will be taken.
- The study period will end 72 hours after the patient has left the intensive care ward, or if there is a permanent change in body position for more than 1 hour or death.
Exclusion Criteria:
- Recent abdominal surgery (<7 days)
- Shock refractory to vasoactive drugs or volume therapy
- Recent intensive care (<30 days)
- Neonates
- Pneumonia at the time of admission to intensive care.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
supine body position
semi-recumbent
Consecutive patients admitted with severe tetanus to the tetanus intensive care ward will be eligible to be included in the study. An envelope for the next study number will be opened in which patients will be randomly allocated to either semi-recumbent (30 degree) or supine (0 degree) body position
Consecutive patients admitted with severe tetanus to the tetanus intensive care ward will be eligible to be included in the study. An envelope for the next study number will be opened in which patients will be randomly allocated to either semi-recumbent (30 degree) or supine (0 degree) body position